Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others ) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

Published Date : Aug 2019

Bioactive Peptide Market – Market Insight Bioactive peptides are amino acids combined together through a covalent bond. Bioactive peptides are extracted from various natural sources, thereby providing a

Coherent Market Insights
Diabetes Nutrition Market, by Product Type (Tablets, Capsules, Powders, Soft Gels, Liquids, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Convenience Stores, Online Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2019 - 2026

To Be Published : Oct 2019

Nutrition is very important part in management of diabetes. Diabetes nutrition products are dietary products that contain less sugar and carbohydrate content. These products help in controlling blood glucose levels. Moreover, diabetes nutrition food contains low calor

Coherent Market Insights
Glycine Market - Size, Share, Trends, and Forecast 2019 - 2027

To Be Published : Oct 2019

Glycine is the simplest amino acid, which is colorless and sweet-tasting crystalline solid. It is insoluble in ethanol and ethyl ether whereas it is moderately soluble in acetone. It helps in healthy functioning of kidney and liver, as it is naturally available in abu

Coherent Market Insights
Magnesium Hydroxide Market - Size, Share, Trends, and Forecast 2019 - 2027

To Be Published : Oct 2019

The global magnesium hydroxide market size is expected to witness potential gains in the future, and register a significant CAGR of 4.3% over the forecast period (2019 - 2027).  

Coherent Market Insights
Sirolimus Market, by Strength (0.5mg, 1mg, 2mg, and 1mg/mL), by Route of Administration (Oral and Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019-2026.

To Be Published : Oct 2019

Sirolimus is a macrolide compound also known as rapamycin, which is a potent immunosuppressant and shows both antifungal and antineoplastic properties. It works by weakening the immune system, and helps your body to accept the new organ, so in this manner it helps in

Coherent Market Insights
Ferrous Fumarate Market - Size, Share, Trends, and Forecast 2019 - 2027

To Be Published : Oct 2019

The global ferrous fumarate market size is expected to witness potential gains in the future, and register a significant CAGR of 15.74% over the forecast period (2019 - 2027). Market Overview

Coherent Market Insights
Anti-Obesity Drugs Market, by Drug Class (Peripherally Acting Anti-Obesity Drugs and Centrally Acting Anti-Obesity Drugs), by Medication Type (Monotherapy and Polytherapy), by Drug Type (Prescription Drugs and OTC Drugs), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019–2026

To Be Published : Oct 2019

Anti-obesity Drugs are pharmacological agents that reduce or control the weight. These drugs change one of the fundamental processes of human body, weight regulation, either by changing the absorption of calories or dipping the hunger. Appetite control is achieved by

Coherent Market Insights
Hemoglobinopathy Treatment Market, by Drug (Hydroxyurea, Glutamine, Zynteglo (autologous CD34+ cells encoding βA-T87Q-globin gene), Luspatercept, and Others), by Disease Type (Sickle Cell Diseases, Thalassemia (Alpha Thalassemia and Beta Thalassemia), and others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Oct 2019

Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body. Hemoglobinopathy disorder are inherited and are passed on from one genera

Coherent Market Insights
Hyperhidrosis Treatment Market, by Drug Class (Anticholinergics and Antiperspirants), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) –Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Oct 2019

Hyperhidrosis is a condition where in a person experiences an excessive sweating. It mainly affects the facial area, hands, feet, and armpit. The sweating is either localized, i.e., the sweating will occur in a particular area or generalized. It further has two subtyp

Coherent Market Insights
Nasal Polyps Treatment Market, by Drug (Fluticasone, Mometasone, Fluticasone, Beclomethasone, Prednisone, and Others), by Route of Administration (Oral, Nasal, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Oct 2019

Nasal polyps are benign growths occurring inside the paranasal sinuses and in the lining of the nose. Generally, it is characterized as a teardrop shaped and yellowish brown or pink in color. The size of the polyps may vary and can be clustered or may grow alone. Thes

Coherent Market Insights
Sarcopenia Treatment Market, by Treatment Type (Protein Supplement, Vitamin D & Calcium Supplement, and Vitamin B12 Supplement), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Hypermarket & Supermarket), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) –Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026

To Be Published : Oct 2019

Sarcopenia means loss of skeletal muscle mass or loss of flesh by aging. Sarcopenia is associated with functional impairments in tasks such as standing up from a chair or lifting 10 pounds and physical disabilities such as not able to perform home chores and personal

Coherent Market Insights
Silver Sulfadiazine Market – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Oct 2019

Silver sulfadiazine is specifically used for second degree or third-degree burns on the skin, which acts ant-bacterial drug. The World Health Organization considers silver sulfadiazine as an Essential Medicines and is used as an antibiotic for skin burns. Silver sulfa

Coherent Market Insights
Regulatory Affairs Outsourcing Market, by Service Type (Regulatory Submission, Regulatory Writing and Publication, Clinical Trail Application and Product Registration, and Regulatory Consulting and Legal Presentation) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2019-2026

To Be Published : Oct 2019

The regulatory affair outsourcing companies are responsible for keeping track about the regulatory requirements specific to regions, in order to ensure that the company have successfully launches and commercializes pharmaceutical products, medical devices, biologics,

Coherent Market Insights
Peptide-based Cardiovascular Therapeutics Market, by Drug Type (Bivalirudin and Eptifibatide), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2019-2027

To Be Published : Oct 2019

Cardiovascular diseases remain a leading cause of mortality and morbidity worldwide. The development of peptide as therapeutic agent has been avoided by pharmaceutical industry due to its low stability, size, degradation rate, and poor stability. However, recently, re

Coherent Market Insights
Enrofloxacin Market - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Oct 2019

The global enrofloxacin market size is expected to witness potential gains in the future, and register a significant CAGR over the forecast period (2019 - 2027). Market Overview

Coherent Market Insights
Aluminum Chloride Hexahydrate Market - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Oct 2019

Aluminum chloride hexahydrate is white to pale in color crystalline powder, which is stable at room temperature. However, it may decompose when it is exposed to moist air or water. According to Oxford University Chemical Safety data, aluminum chloride hexahydrate has

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.